| |
Controlled Release
|
Kollicoat® SR 30 D |
| Kollicoat® SR 30 D is a polyvinyl acetate dispersion with
27% polyvinyl acetate as a filmformer and with 2.7% povidone and 0.3% sodium Iauryl sulfate
as stabilizers. The total solid content is 30%. It is used in coated sustained-release formulations
or matrix tablets with pH-independent release characteristics. |
|
Kollicoat® MAE 30 DP |
| Methacrylic acid-ethyl acrylate copolymer (1:1)
in the form of a 30% aqueous dispersion for enteric coating of crystals, pellets, tablets and capsules. |
|
Kollicoat® MAE 100 P |
| Redispersible methacrylic acid-ethyl acrylate copolymer
(1:1) in powder form for enteric coating of crystals, pellets, tablets and capsules. |
|
Kollidon® SR |
| Kollidon® SR is a blend of 80% polyvinyl acetate and 20%
povidone in powder form. This excipient is used in sustained-release matrix tablets that are
manufactured by direct compression and have pH-independent release characteristics. |
|
|
 |
News |
| |
|
April 30, 2008:
BASF sells its Shreveport site and related contract manufacturing business to Dr. Reddy's Laboratories
(english, deutsch) January 18, 2008:
BASF appoints Folker Ruchatz as head of its custom synthesis business
(english, deutsch) November 12, 2007:
BASF to raise prices for pharma excipients
(english, deutsch)
|
|
 |
Product Search |
 |
|
 |
Order Samples |
|
| |
|